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Axon morphogenesis is a complex process regulated by a variety of secreted molecules,
including morphogens and growth factors, resulting in the establishment of the
neuronal circuitry. Our previous work demonstrated that growth factors [Neurotrophins
(NT) and Hepatocyte Growth Factor (HGF)] signal through β-catenin during axon
morphogenesis. HGF signaling promotes axon outgrowth and branching by inducing
β-catenin phosphorylation at Y142 and transcriptional regulation of T-Cell Factor (TCF)
target genes. Here, we asked which genes are regulated by HGF signaling during
axon morphogenesis. An array screening indicated that HGF signaling elevates the
expression of chemokines of the CC and CXC families. In line with this, CCL7, CCL20, and
CXCL2 significantly increase axon outgrowth in hippocampal neurons. Experiments using
blocking antibodies and chemokine receptor antagonists demonstrate that chemokines
act downstream of HGF signaling during axon morphogenesis. In addition, qPCR
data demonstrates that CXCL2 and CCL5 expression is stimulated by HGF through
Met/b-catenin/TCF pathway. These results identify CC family members and CXCL2
chemokines as novel regulators of axon morphogenesis downstream of HGF signaling.
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INTRODUCTION
The establishment of the neuronal morphogenesis is a com-
plex process by which neurons extend and branch out an axon
and dendrites, resulting in the proper assembly of the neuronal
circuitry. A range of secreted molecules, including growth fac-
tors and morphogens, promote axonal, and dendrite outgrowth.
Among them, the Neurotrophins (NT), Hepatocyte Growth
Factor (HGF), and Wnts regulate neuronal survival, neurite
outgrowth, synaptogenesis, and synaptic plasticity (Maina and
Klein, 1999; Korhonen et al., 2000; Chao, 2003; Yu and Malenka,
2003; Ciani and Salinas, 2005; Nakano et al., 2007; Park and
Shen, 2012). HGF signaling through its tyrosine kinase recep-
tor Met provides neurotrophic signals to hippocampal neurons
(Korhonen et al., 2000) and promotes axon outgrowth (David
et al., 2008). How neurons interpret this variety of signals to
develop unique axon arbor morphologies is just beginning to be
understood.
β-catenin, a component of the cell–cell adhesion complex
and an effector of canonical Wnt signaling, plays a key role
in axon outgrowth, dendritogenesis, and synapse formation
(Murase et al., 2002; Bamji et al., 2003, 2006; Yu and Malenka,
2003; Lu et al., 2004). Briefly, canonical Wnt signaling results in
the cytosolic stabilization of β-catenin, which in the absence of
Wnt is degraded through the ubiquitin-proteasome system (Li
et al., 2012). Stabilized β-catenin translocates to the nucleus and
together with Lymphoid Enhancer Factor-1 (LEF-1)/T-cell factor
(TCF) transcription factors regulates the expression ofWnt target
genes (Behrens et al., 1996; Molenaar et al., 1996). On the other
hand, β-catenin binding to the adhesion complex components
cadherin and α-catenin is altered by β-catenin tyrosine phospho-
rylation, resulting in the downregulation of cell adhesion and
the promotion of migration (Nelson and Nusse, 2004; Heuberger
and Birchmeier, 2010). We previously showed a requirement
for β-catenin phosphorylation at Y654 and Y142 in the axon
outgrowth promoted by the NT and HGF signaling, respec-
tively. HGF signaling induces the phosphorylation of β-catenin
at Y142 (PY142), which translocates to the nucleus and pro-
motes axon morphogenesis through TCF4/β-catenin-dependent
transcription of target genes (David et al., 2008). These findings
highlight the relevance of β-catenin forms producing transcrip-
tional regulation independent of Wnt signaling (Monga et al.,
2002; Zeng et al., 2006; Heuberger and Birchmeier, 2010; Xi et al.,
2012).
Chemotactic cytokines (“chemokines”) are small proteins clas-
sified into four subgroups referred to as CXC/α, CC/β, CX3C/δ,
or C/δ families (Zlotnik and Yoshie, 2000; Tran and Miller, 2003)
according to the position and spacing of cysteine residues impor-
tant for their tri-dimensional structure. Chemokines are best
known for their role in leukocyte migration in host immune
surveillance and inflammatory responses. However, chemokines
and their G-protein-coupled receptors are also expressed by neu-
rons and glia in the nervous system. Interestingly, chemokines of
the CXC and CC families have been implicated in proliferation,
neurogenesis, and neuronal differentiation of neural precursors
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(Tran and Miller, 2003; Edman et al., 2008a,b; Wu et al., 2009).
Meningeal CXCl12/Sdf-1 signaling through its receptor CXCR4
regulates the migration of cerebellar progenitors (Zou et al., 1998;
Reiss et al., 2002) and Cajal-Retzius cells (Borrell and Marin,
2006). CXCL12 also controls interneuronmigration during corti-
cal development (Stumm et al., 2003; Lopez-Bendito et al., 2008;
Lysko et al., 2011; Sanchez-Alcaniz et al., 2011; Wang et al., 2011).
Furthermore, CXCL12 reduces axon outgrowth and branching
in hippocampal neurons (Pujol et al., 2005). Importantly, neu-
ronal migration and morphogenesis are coordinated processes
that appear inversely regulated by CXCL12 signaling. CXCL12
increases the rate of interneuronmigration while reducing neurite
branching, whereas blocking CXCL12 signaling enhances neu-
rite branching, thus explaining how interneurons switch from
migratory streams to invade the cortical plate and branch out
extensively (Lysko et al., 2011). Moreover, astrocyte-secreted
CCL5/Rantes induces the outgrowth of cortical neuron neurites
(Chou et al., 2008). CCL5 secretion is suppressed in astrocytes
from a Huntington mouse model (Chou et al., 2008), indicating
that chemokine signaling is involved in neuronal physiology and
pathology.
Here we asked which are the genes regulated by HGF/β-
catenin signaling during axon morphogenesis. We observe that
expression of CC and CXC chemokines is upregulated by HGF
signaling in hippocampal neurons. We find that chemokines
promote axon outgrowth in hippocampal neurons, the most
remarkable one being CXCL2 that also stimulates axon branch-
ing. Experiments using chemokine blocking antibodies and phar-
macological inhibitors of chemokine receptors demonstrate that
chemokines act downstream of HGF signaling. We also show
that chemokine expression is reduced upon Met and TCF inhi-
bition. These results identify the chemokines as novel regulators
of axon morphogenesis downstream of HGF and β-catenin/TCF
signaling.
MATERIALS AND METHODS
MATERIALS
HGF was purchased from Peprotech, Wnt-3a from Millipore,
Hoescht-33258, SU11274, and FH535 were from Sigma, and
SB225502 and SB324837 from Tocris. Antibodies were purchased
from the following companies: βIII-tubulin from Covance,
β-actin from Sigma, β-catenin from Becton-Dickinson and anti-
rat CCL20 and CXCL2 antibodies from R&D. Rat CCL5, CCL7,
CCL20 were from R&D Systems and CXCL2 from Peprotech.
HIPPOCAMPAL CULTURES
Rat primary hippocampal neurons were isolated from 18–19
day embryos and cultured in DMEM medium supplemented
with N2 and B27. Neurons were plated on poly-D-lysine coated
(500μg/ml) glass coverslips for immunostaining (40 cells/mm2)
or on plastic (1000–1500 cells/mm2) for RNA isolation.
IMMUNOFLUORESCENCE AND AXON MEASUREMENTS
Neurons plated on coverslips were treated at the first day in
vitro (1DIV) and fixed at 2DIV. Treatments were as follows:
10, 300, or 1000 ng/ml for chemokines; HGF 50 ng/ml; Wnt-3a
100 ng/ml; SU11274 2μM; FH535 10μM; SB225502 1.25 nM;
SB324837 20 nM; blocking antibodies against rat CCL20 and
CXCL2 (40μg/ml) or ovalbumin at the same concentration.
Neurons were fixed with 4% paraformaldehyde (PFA) for 20min
at RT. Cells were then washed with phosphate buffer saline (PBS)
and blocked and permeabilized in PBS containing 5% Foetal
calf serum, 5% Horse serum, 0.2% glycine, and 0.1% Triton
X100, before incubation with βIII-tubulin antibody. Secondary
antibodies were Alexa Fluor488 or Fluor594 (Molecular Probes).
Coverslips were mounted onMowiol. Micrographs were obtained
using an inverted Olympus IX70 microscope (10×, 0.3 NA, or
20×, 0.4 NA) equipped with epifluorescence optics and a camera
(Olympus OM-4 Ti). Images were acquired using DPMManager
Software and processed using MacBiophotonics ImageJ software
(www.macbiophotonics.ca). Axon length was measured using
Adobe Photoshop software and the axon was identified as the
longest neurite at this stage (2 DIV) of the hippocampal cell
development. Images were inverted using Photoshop and are
shown on a white background for a clearer visualization of their
morphology. Branching was measured by counting Total Axonal
Branch Tip Number (TABTN) (Yu andMalenka, 2003). Typically,
15–20 neurons were measured/condition in ≥ three indepen-
dent experiments. Axon length and branching plots represent
values compared to the corresponding untreated control, shown
as average ± s.e.m. Significance was calculated by the Student’s
t-test. Asterisk (∗) indicates statistical significance compared to
the corresponding untreated control and hash (#) compared to
stimulated controls (see legends for details).
LUCIFERASE ASSAY
To determine β-catenin transcriptional activation status,
luciferase assay was performed following transfection of the
TOP-Flash plasmid that carries a synthetic promoter containing
three copies of the TCF-4 binding site upstream of a firefly
luciferase reporter gene. Hek293T cells were plated at a density
of 100 cells/mm2 and transfected with Lipofectamine 2000 (Life
Technologies) on the day next after plating. Treatments were
given on the following day for 24 h (HGF 50 ng/ml; Wnt-3a
100 ng/ml; FH535 8μM and SU11274 2μM). After 48 h of
transfection, cells were lysed in lysis buffer 25mM glycylglycine,
pH 7.8, 15mM Mg2SO4, 1% Triton X-100, 5mM EGTA and
rocket on ice for 15min. Luciferase activity in the cell lysates was
determined in Luciferase Buffer (25mM glycylglycine, 15mM
KHPO4, pH 7,8, 15mMMg2SO4, 1% Triton X-100, 5mMEGTA,
1mM dithiothreitol, 2mM ATP, 100mM acetyl-coenzymeA, and
100mM luciferine) using a microplate luminometer. Luciferase
activity was normalized for the total protein concentration in
each condition.
shRNA EXPRESSION BY LENTIVIRAL INFECTION
shRNA vectors specific for rat β-catenin were transfected into
Hek293T cells together with the plasmids psPAX2 and pMD2G,
as previously described (David et al., 2008). The Hek293T
medium was collected after 48 h of transfection and centrifuged
at 50,000×g for 3 h. The viral pellet was re-suspended in ster-
ile PBS plus 2% Bovine Serum Albumin. Hippocampal neurons
were transduced 3–4 h after plating. According to GFP expression
driven by the lentiviral vector ∼90% of neurons were transduced.
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Neurons were treated with HGF alone or together with pharma-
cological inhibitors at 3 DIV and collected at 4DIV for mRNA
purification (RNA isolation kit; Macherey-Nagel). Efficiency of
the silencing induced by shRNA was evaluated by Western-
blotting of 4DIV hippocampal neuron cell lysates. Densitometric
analysis of the bands was performed using Scion software and
β-catenin levels were normalized to the intensity of β-actin band.
RNA ISOLATION
For RNA isolation, treatments were performed as for immunoflu-
orescence studies. Pervanadate was applied for the last 2 h of
HGF stimulation. RNA was isolated using Nucleospin RNA II kit
(Macherey-Nagel), including a DNase digestion step to remove
contaminant DNA.
ARRAY PROCESSING AND ARRAY DATA ANALYSIS
RNA samples (800 ng) were amplified and labeled with Cy3-
CTP using the One-Color Microarray-Based Gene Expression
Analysis Protocol (Agilent Technologies, Palo Alto, CA, USA) and
hybridized to Whole Rat Genome Microarray 4 × 44K (G4131F,
Agilent Technologies).
Raw data files from the scanned arrays were extracted using
Feature Extraction software version 9 (Agilent Technologies).
Data files from Feature Extraction software were imported into
GeneSpring® GX software version 9.0. (Agilent Technologies).
Quantile normalization was performed (Bolstad et al., 2003)
and expression values (log2 transformed) were obtained for each
probe. Probes were also flagged (Present, Marginal, Absent) using
GeneSpring® default settings. Probes with signal values above
the lower percentile (20th) and flagged as Present or Marginal
in 100% of replicates in at least one out of the two conditions
under study, were selected for further analysis. Paired t-test was
performed between conditions to be tested for differential expres-
sion analysis. Raw p-values were corrected for false discovery rate
control using Benjamini–Hochsberg’s method (Benjamini and
Hochberg, 1995).
REVERSE-TRANSCRIPTASE PCR
mRNA was reverse-transcribed (RT) to cDNA (25◦C for 10min,
42◦C for 60min, and 95◦C for 5min) using random hexam-
ers and Superscript II reverse transcriptase (Applied Biosystems).
Negative control RT-minus reactions were carried out to confirm
absence of DNA contamination in RNA.
SEMI-QUANTITATIVE PCR
To detect the relative expression of different chemokine genes
in HGF-treated and untreated samples, semi-quantitative (sq)
PCR was run. Equal volumes of cDNA were amplified by
PCR using a couple of specific primers expanding at least
two exons within the gene of interest. Sequences of the
primers used were: CCL5 forward atatggctcggacaccactc, CCL5
reverse cccacttcttctctgggttg, CCL7 forward gggaccaattcatccacttg,
CCL7 reverse cctcctcaacccacttctga, CCL20 forward gcttacctct-
gcagccagtc, CCL20 reverse cggatcttttcgacttcagg, CXCL2 forward
agggtacaggggttgttgtg, CXCL2 reverse tttggacgatcctctgaacc. Ten
microlitre aliquots taken from 25, 30, and 35 PCR cycles (CXCL2
and CCL7), 30, 34, and 38 PCR cycles (CCL5) or 24 and 28 PCR
cycles (CCL20) were analyzed in 3% agarose gel. Densitometry of
the DNA bands was performed using the Scion Image software
(Scion Corporation) and comparing measurements from non-
saturated PCR products. Loading was checked by amplification of
the GAPDH transcript. Transcript analysis was performed from at
least three independent simples.
REAL TIME PCR (qPCR)
cDNA processed from 1μg RNA was used as the template. One
microlitre aliquot of each cDNA was used per well. Samples
were run in triplicate. Expression of the transcript levels were
analysed using a FAM-labeled CXCL2 or CCL5 probes and com-
pared to that of GAPDH, used as a loading control, in a ABI
Prism 7000HT sequence detection system (Applied Biosystems).
Relative expression was calculated using the C1 method.
RESULTS
CHEMOKINES OF THE CC AND CXC FAMILIES ARE UPREGULATED BY
HGF TREATMENT
Previous work demonstrated that HGF signals through PY142
β-catenin and TCF4 to regulate the expression of target genes
FIGURE 1 | Chemokine genes are upregulated by HGF signaling in
2DIV hippocampal neurons. (A) Summarized array data (left) indicating
the chemokine genes that are upregulated in HGF-treated (50 ng/ml, 24 h)
compared to untreated hippocampal neurons. (Right) Summary of the
quantification of sqPCR experiments. Values indicate fold change of the
chemokine expression in HGF-treated vs. untreated samples ± s.e.m.
(≥3 experiments). (B) Representative sqPCR of samples taken at the
indicated PCR cycle to compare the expression of chemokines in untreated
and HGF-treated hippocampal neurons. GAPDH was used as a
housekeeping gene (image corresponds to 30 PCR cycles). RT-indicates
samples in which reaction was run without RT enzyme.
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during hippocampal neuron development (David et al., 2008).
We questioned which are the genes regulated upon HGF stimu-
lation in axon morphogenesis. We performed array experiments
using control and HGF-treated hippocampal neuron samples.
Array results revealed an upregulation of several chemokine
genes in HGF-treated neurons compared to untreated neurons
(Figure 1A), which was confirmed by sqRT-PCR (Figures 1A,B).
In silico analysis of the 2 kb region upstream of the ATG in
the identified chemokine genes showed the presence of sev-
eral copies of putative TCF-binding sites, as predicted for
β-catenin/TCF-target genes (data not shown). These findings
indicated that chemokines may be involved in the HGF-induced
axon morphogenesis.
CHEMOKINE SIGNALING PROMOTES AXON MORPHOGENESIS
To address this possibility, we first tested whether chemokines
induce axon outgrowth and branching. Hippocampal neurons
were treated with CCL5, CCL7, CCL20, or CXCL2 at differ-
ent concentrations (10–1000 ng/ml). CCL5 (10 ng/ml), CXCL2
(300 and 1000 ng/ml), and CCL20 (10 and 1000 ng/ml) sig-
nificantly increased the total length of the axon compared to
axon length values of untreated neurons (Figure 2). A cocktail
of all the chemokines (10 ng/ml) also increased axon outgrowth
(Figure 2I). The increases in axon length were in the range
of that obtained by HGF stimulation (Figure 2I). In addition
to increasing axon length, CXCL2 also produced axon branch-
ing (Figure 2J). Axon branching was not significant for the
other studied chemokines at the tested concentrations (data not
shown).
Having showed that exogenously added chemokines induce
axon morphogenesis in hippocampal neurons, we studied
whether blocking chemokine signaling would inhibit the effect of
HGF on axonmorphogenesis. To this end, we used blocking anti-
bodies against the chemokines as well as the chemokine receptor
antagonists SB2250002 and SB328437 (White et al., 1998, 2000).
Neurons incubated with HGF together with antibodies against
rat CXCL2 or CCL20 (40μg/ml) displayed axon length and
branching values similar to those of untreated neurons (Figure 3).
However, the increase in axon length promoted by HGF was not
affected by the presence of ovalbumin at the same concentra-
tion than the antibodies (40μg/ml). Furthermore, treatment with
HGF and the antagonist for the receptor of CXCL2 (CXCR2)
FIGURE 2 | Recombinant chemokines increase axon morphogenesis.
(A–H) Hippocampal neurons (2DIV) control or treated with CXCL2, CCL5,
CCL20, and CCL7 (1000 ng/ml) and immunostained for βIII-tubulin to reveal
the axon morphology. Images (A–E) were taken at 10× and (F–H) at 20×.
Bars = 30μm. Average axon length compared to control (I) and axon
branching shown as an increase vs. control (J) for chemokine treatments at
the indicated dose or HGF (50 ng/ml). All refers to a cocktail of the four
chemokines (10 ng/ml). ∗p ≤ 0.05, ∗∗p ≤ 0.01, and ∗∗∗p ≤ 0.001.
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FIGURE 3 | Chemokine signaling is involved in the axon morphogenesis
promoted by HGF. (A) Hippocampal neurons treated with HGF (50 ng/ml)
together with anti-CCL20 (40 ug/ml), anti-CXCL2 (40μg/ml), SB225502
(1.25 nM) or SB324837 (20 nM), and immunostained for βIII-tubulin. Top
pictures were taken at 10× and bottom at 20×. Bars = 30μm. (B and C)
Average axon length measurements (B) and axon branching shown as an
increase vs. control (C). All refers to a cocktail of the four chemokines
(10 ng/ml). ∗∗p ≤ 0.01 and ∗∗∗p ≤ 0.001 when comparing to control neurons.
#p ≤ 0.05, ##p ≤ 0.01, and ###p ≤ 0.001 when comparing to HGF-treated
neurons.
SB2250002, or with SB328437, an antagonist of CCR3 (that acts
as the only receptor of CCL20 and one of the receptors of CCL5),
potently inhibited axon outgrowth and branching to values below
those of control neurons (Figure 3). These results suggest that
CXCL2 and CCL20 are secreted upon HGF stimulation and that
endogenous CXCL2 and CCL20 signaling plays a role in axon
morphogenesis.
HGF REGULATES CXCL2 EXPRESSION THROUGH MET AND
β-CATENIN/TCF
We sought to study the pathway regulating chemokine expres-
sion downstream of HGF signaling. We demonstrated that HGF
stimulation induces PY142 β-catenin phoshorylation and tran-
scriptional regulation by TCF/β-catenin (David et al., 2008).
To check if chemokine expression is controlled by TCF and
β-catenin downstream of HGF signaling, we followed both
a pharmacological and a gene silencing approach. We used
SU11274 that inhibits Met activity (Berthou et al., 2004) and
FH535, which inhibits TCF/β-catenin by blocking the recruit-
ment of β-catenin to the promoter of target genes (Handeli
and Simon, 2008). First, we studied β-catenin transcriptional
activation using the TOP reporter plasmid in Hek293 cells,
in which HGF/Met signaling is active (Royal and Park, 1995).
Although HGF did not stimulate luciferase reporter activity
vs. control, treatment with SU11274 significantly reduced β-
catenin transcriptional activation (Figure 4B). This result sug-
gests that in Hek293 cells, HGF/Met signaling through β-catenin
is already active in basal conditions, likely by an autocrine
production of HGF. Furthermore, treatment with FH535 sig-
nificantly reduced luciferase activity, demonstrating that TCF
activation is involved in HGF/Met signaling (Figure 4B). We
used Wnt-3a as a positive control, which produced a clear acti-
vation of luciferase activity and was also inhibited by FH535
(Figure 4B). These results confirmed FH535 as an effective
TCF/β-catenin inhibitor and indicated that HGF/Met signal
through TCF/β-catenin in Hek293 cells among other cell systems
(Monga et al., 2002).
In hippocampal neurons, both SU11274 and FH535 inhibited
the axon outgrowth induced by HGF signaling (Figure 4A). As
a positive control we also treated neurons with Wnt-3a with or
without FH535. As expected, TCF inhibitor blocked the axon out-
growth promoted by Wnt-3a. FH535 treatment also blocked the
axon outgrowth promoted by HGF, rendering axon length val-
ues below those of control neurons, thus confirming that HGF
signaling is dependent on TCF-driven transcription (David et al.,
2008).
Next, we investigated whether chemokine expression is reg-
ulated through the HGF/Met/TCF/β-catenin pathway. Because
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FIGURE 4 | Met and TCF inhibition reduce the axon outgrowth
induced by HGF. (A) Hippocampal neurons treated with HGF (50 ng/ml)
or Wnt-3a (100 ng/ml) alone or together with FH535 (10μM) or SU11274
(2μM) were immunostained for βIII-tubulin to reveal the axon
morphology. Top pictures were taken at 10× and bottom at 20×.
Bars = 30μm. (B) β-catenin transcriptional activity determined using the
TOP reported plasmid in transfected Hek293 cells. Relative luciferase
activity was determined at 48 h after transfection. Treatments were
applied for the last 24 h (see Materials and Methods for details).
∗p ≤ 0.05, ∗∗p ≤ 0.01.
CXCL2 promoted both axon outgrowth and branching, we
focused on this chemokine and on CCL5 as a member of the
CC family. We analyzed the expression of these chemokines using
real time qPCR from control neurons, neurons treated with
HGF or treated with HGF together with SU11274 or FH535.
Expression of CXCL2 increased by 1.6-fold in HGF-treated neu-
rons compared to untreated neurons, but was reduced to values
below those of untreated neurons following the treatment with
HGF and SU11274 (Figure 5A). Pervanadate (a tyrosine phos-
phatase inhibitor) was previously used to stabilize the PY142-
β-catenin form (David et al., 2008). However, HGF stimulation
increased CXCL2 expression in pervanadate-treated neurons in
a similar way than in the absence of pervanadate (Figure 5B).
Furthermore, the increase in CXCL2 expression induced by HGF
signaling was lost upon the co-treatment of HGF and FH535
(Figure 5A), indicating that it was mediated by TCF/β-catenin.
In addition, we analyzed CXCL2 mRNA levels in hippocampal
neurons in which β-catenin was silenced following lentiviral-
driven shRNA expression. The silencing efficiency obtained with
this β-catenin shRNA at four days was around 40–50% as sim-
ilarly reported (David et al., 2008, 2010). Whereas HGF was
able to increase the expression of CXCL2 in neurons expressing
scrambled shRNA, this increase was lost in neurons expressing
β-catenin shRNA (Figure 5C). We also analyzed the expression
of CCL5, which increased nearly 2-fold upon HGF stimulation
and was significantly reduced in the presence of HGF and FH535
(Figure 5D).
DISCUSSION
Aiming to identify the genes regulated by HGF signaling in
developing hippocampal neurons during axon morphogenesis,
we found the upregulation of several chemokines of the CC and
CXC families. Following array experiments, we demonstrated that
CCL5, CCL20, and CXCL2 significantly promote axon outgrowth
and, in the case of CXCL2, also axon branching. PCR data con-
firmed that chemokines are upregulated by HGF signaling. By
blocking chemokine signaling, we demonstrated that CCL20 and
CXCL2 act downstream of HGF signaling in axon outgrowth
and branching. During the establishment of the axon arbor
morphology, HGF signaling induces β-catenin PY142 and TCF4-
dependent transcriptional regulation of target genes (David et al.,
2008). We inquired whether chemokines are regulated through
TCF/β-catenin downstream of HGF signaling. TCF inhibition
or β-catenin silencing reduced CXCL2 and CCL5 expression
upon HGF stimulation. We conclude that chemokines are new
molecules modulating axon outgrowth in hippocampal neurons,
which expression is regulated by HGF through TCF/β-catenin
signaling.
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FIGURE 5 | CXCL2 and CCL5 expression is regulated by HGF signaling
throughTCF/β-catenin. (A) qPCR analysis indicates that CXCL2 relative levels
in 2DIV hippocampal neurons increase upon HGF stimulation (50 ng/ml, 24 h),
decrease below control levels in neurons co-treated with SU11274 (2μM) plus
HGF and remain similar to control levels in neurons co-treated with FH535
(10μM)plusHGF. (B)CXCL2relative levels uponHGFstimulation inpervanadate
(perv)-treated (last 2 h) neurons. (C) CXCL2 relative levels in 4DIV hippocampal
neurons transduced with lentiviral vectors driving the expression of scrambled
or β-catenin shRNAs, untreated or treated with HGF stimulation, indicate that
HGF does not increase CXCL2 levels in neurons expressing β-catenin shRNA.
Lower panel: Western-blot for β-catenin shows a reduction in β-catenin levels in
hippocampal neurons expressing scrambled (scr) or β-catenin (β-cat) shRNAs.
β-actin was used as a loading control. (D) CCL5 relative levels (4 DIV) increase
by HGF and significantly decrease when neurons were co-treated with HGF
and FH535. ∗p ≤ 0.05, ∗∗p ≤ 0.01 when comparing to control neurons.
#p ≤ 0.05, ##p ≤ 0.01 when comparing to HGF-treated neurons.
CHEMOKINE SIGNALING IN NEURONAL MIGRATION AND AXON
OUTGROWTH
Chemokines are well-established chemotactic molecules induc-
ing the migration of leukocytes and hematopoietic progenitors
(Rossi and Zlotnik, 2000). In the nervous system, chemokines
and chemokine receptor expression are regulated under a vari-
ety of conditions, including brain repair (Babcock et al., 2003;
Miller et al., 2008; Jaerve et al., 2012). Thus, chemokine signal-
ing has been involved in neuroinflammation, the pathogenesis
of chronic pain (White et al., 2005), myelination (Kury et al.,
2002) and human immunodeficiency virus-1 (HIV-1)-associated
neuropathology (Tran and Miller, 2003). Furthermore, a role for
chemokines (in particular for CXCL12/Sdf-1) in regulating axon
outgrowth and guidance has also been described during nervous
system development (Tran and Miller, 2003). CXCL12-CXCR4
signaling is involved in the guidance of motoneuron’s axon
(Lieberam et al., 2005) and downstream of Sonic Hedgehog sig-
naling in retinal ganglion cell axon pathfinding (Stacher Horndli
and Chien, 2012). CXCL12 can either produce growth cone
repulsion or attraction depending on the levels of cGMP (Xiang
et al., 2002). Remarkably, CXCL12 signaling regulates the migra-
tion of different neuron and neuronal progenitor populations:
gonadotropin-releasing hormone-1 neurons emerging from the
nasal placode (Casoni et al., 2012), interneurons moving from
the medial ganglionic eminence toward the cortical plate (Lopez-
Bendito et al., 2008; Lysko et al., 2011), cerebellar progenitors
(Zou et al., 1998; Vilz et al., 2005) and sensory neuron progen-
itors toward dorsal root ganglia (Belmadani et al., 2005). CCL2,
CCL7, and their receptors are expressed during midbrain devel-
opment, promoting the differentiation of dopaminergic neurons
and also neuritogenesis (Edman et al., 2008a,b). To our knowl-
edge, this is the first work reporting that CC chemokines induce
axonmorphogenesis in hippocampal neurons. In agreement with
our data, in situ hybridization data freely available online reveals
the expression of chemokines in the mouse hippocampus during
embryonic and adult life (see Genepaint and Allen Brain Atlas
webpages). CXCL12 was shown to promote the extension of per-
forant fibers from the entorhinal cortex to dentate gyrus neurons
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and the migration of dentate granule cells during hippocam-
pal development (Bagri et al., 2002; Lu et al., 2002; Ohshima
et al., 2008). In addition, CXCL12 reduces axon elongation while
promoting axon branching in dissociated hippocampal neurons
(Pujol et al., 2005). We found that CXCL2 increases total axon
length and axon branching in hippocampal neurons, suggesting
that it plays a role in vivo during hippocampal development. In
line with an effect of chemokines inducing axon development,
mice lacking chemokine receptors showed impairments in hip-
pocampal cognitive function and synaptic plasticity (Rogers et al.,
2011; Belarbi et al., 2013).
HGF/β-CATENIN SIGNALING AND CHEMOKINES
Our findings establish a relationship between HGF and
chemokine signaling in hippocampal neurons. HGF-treated neu-
rons displayed increased expression of chemokines. Antibodies
against CCL20 and CXCL2, as well as the CCR3 and CXCR2
antagonists SB22502 and SB328437, inhibited the axon out-
growth and branching promoted by HGF, implying that
chemokines are downstream of HGF signaling. Moreover, treat-
ment with SB22502 or SB328437 resulted in axon length and
branching values clearly below those of untreated neurons, sug-
gesting that endogenous chemokine production by hippocampal
neurons impacts on axon development. Furthermore, affecting
CCL20 signaling by anti-CCL20 antibodies or SB328437 treat-
ment reduced axon branching in the presence of HGF. However,
CCL20 at the tested concentrations (10–1000 ng/ml) did not pro-
mote significant axon branching. These findings suggest that
promotion or inhibition of axon branching exhibit different
EC50/IC50 values. Alternatively, CCL20 concentrations lower
than tested may induce axon branching.
β-catenin is a classical effector of Wnt signaling and a tran-
scriptional coactivator of LEF/TCF. We and others have described
the interaction between Met and β-catenin (Monga et al., 2002;
Zeng et al., 2006; David et al., 2008), which results in β-catenin
phosphorylation at Y142 in vitro (David et al., 2008). In hip-
pocampal neurons, HGF signaling increases PY142-β-catenin,
which moves to the nucleus and regulates axonal morphogenesis
through TCF4-transcriptional activation (David et al., 2008).
Here, we confirm that HGF/Met signaling supports axon out-
growth through TCF/β-catenin transcriptional activity. In line
with these findings, the phosphorylation of β-catenin and α-
catenin downstream of tyrosine kinase receptor and/or src acti-
vation is emerging as a Wnt-independent pathway that promotes
β-catenin transcriptional activation and migration of cancer
cells (Ji et al., 2009; Xi et al., 2012). In this work chemokines
were identified as transcriptional targets of HGF in developing
in hippocampal neurons. CXCL2 and CCL5 expression anal-
ysis confirmed that these chemokines are regulated by HGF
signaling. In addition, TCF inhibition and β-catenin silencing
blocked the upregulation of CXCL2 by HGF. A previous paper
(Halleskog et al., 2011) described the upregulation of cytokines
and chemokines—including CXCL2—by Wnt-3a and β-catenin
signaling in activated microglia. TCF inhibition also reduced the
expression of CCL5 following HGF stimulation (by ∼30% com-
pared to HGF-treated neurons), suggesting that CCL5 is at least
in part regulated through TCF/β-catenin downstream of HGF
signaling. It is possible that HGF signaling activates another path-
way, i.e., NFkB pathway that affects CCL5 expression (Chou et al.,
2008).
In summary these findings add different chemokines to
the growing list of secreted molecules that modulate axon
outgrowth, and highlights new developmental roles for sig-
naling molecules known to regulate immune cell biology. As
chemokines play a role in post-ischemic brain repair (Wang
et al., 2012) and recruiting stem cells after spinal cord
injury (Jaerve et al., 2012), it is tempting to speculate that
chemokines at the injury site may serve to improve axon
regeneration.
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